These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3994204)

  • 41. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
    Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fungal infections: involved species and minimal inhibitory concentrations of common antifungal agents].
    Dei-Cas E; Fruit J; Poulain D; Dutoit E; Chendid H; Vernes A
    Ann Biol Clin (Paris); 1984; 42(6):415-8. PubMed ID: 6543419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
    Mazari W; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Goudard M; Regli P; Buffard Y; Gabriel B
    Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of resistance to amphotericin B and caspofungin in Candida spp.: experimental study.
    Soler L; Pastor E; Rodriguez JC; Ruiz M; Lopez P; Cremades R; Royo G
    J Chemother; 2009 Aug; 21(4):467-9. PubMed ID: 19622473
    [No Abstract]   [Full Text] [Related]  

  • 48. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan.
    Yang YL; Ho YA; Cheng HH; Lo HJ;
    Epidemiol Infect; 2005 Apr; 133(2):325-30. PubMed ID: 15816158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
    Garavelli PL; Michelone G; Cavanna C; Maccabruni A
    Minerva Med; 1988 Apr; 79(4):265-6. PubMed ID: 3163414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development of resistance by candida species to polyene antibiotics in vitro.
    Athar MA; Winner HI
    J Med Microbiol; 1971 Nov; 4(4):505-17. PubMed ID: 5316339
    [No Abstract]   [Full Text] [Related]  

  • 55. Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents.
    Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
    Chemotherapy; 1996; 42(2):107-11. PubMed ID: 8697885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stearidonic acid acts in synergism with amphotericin B in inhibiting Candida albicans and Candida dubliniensis biofilms in vitro.
    Thibane VS; Kock JL; Van Wyk PW; Ells R; Pohl CH
    Int J Antimicrob Agents; 2012 Sep; 40(3):284-5. PubMed ID: 22817915
    [No Abstract]   [Full Text] [Related]  

  • 57. An analysis of the in vitro mycostatic activity of some of the antifungal antibiotics on fungal strains isolated from patients treated with these antibiotics.
    Kurnatowska A; Kwasniewska J
    Mater Med Pol; 1978; 10(3):166-9. PubMed ID: 723290
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.